BMJ Open (Nov 2022)

Understanding the clinical profile of patients with frozen shoulder: a longitudinal multicentre observational study

  • Mira Meeus,
  • Alejandro Luque-Suarez,
  • Santiago Navarro-Ledesma,
  • Manuel Fernandez-Sanchez,
  • Filip Struyf,
  • Suzie Noten,
  • ERIK FRANSEN,
  • Michel GCAM Mertens,
  • Olivier Verborgt,
  • Enrique Lluch Girbés,
  • Marta Aguilar Rodríguez,
  • Lirios Dueñas

DOI
https://doi.org/10.1136/bmjopen-2021-056563
Journal volume & issue
Vol. 12, no. 11

Abstract

Read online

Introduction There is a large diversity in the clinical presentation of frozen shoulder (FS) and the clinical outcome is not always satisfactory. The aim of the current study was to examine to what extent range of motion (ROM) limitation, metabolic factors (diabetes mellitus and thyroid disorders), autonomic symptoms and pain sensitivity may contribute to the prognosis in terms of shoulder pain and disability and quality of life in patients with FS.Methods Patients with stage 1 or 2 FS were longitudinally followed-up during 9 months after baseline assessment. They completed six questionnaires and underwent quantitative sensory testing (pressure pain thresholds, temporal summation and conditioned pain modulation) and ROM assessment.Results One hundred and forty-nine patients with FS were initially recruited and 121 completed at least one follow-up measurement. Shoulder pain and disability improved over time and diabetes mellitus was found to be a prognostic factor for final outcome. Several domains of quality of life also improved over time and external rotation ROM, diabetes mellitus, thyroid disorder and autonomic symptoms were found to be prognostic factors for final outcome. These prognostic factors explained 2.5%–6.3% of the final outcome of shoulder pain and disability and quality of life.Discussion and conclusion In patients with FS, prognostic variables were able to predict different outcomes, indicating that outcomes in this population can be variable-dependent. Other variables not explored in this study might contribute to the prognosis of patients with FS, which should be investigated in future research. In clinical practice, baseline assessment of prognostic factors and focusing on a more holistic approach might be useful to inform healthcare practitioners about progression of patients with FS during a 9-month period.